2015
DOI: 10.1111/neup.12241
|View full text |Cite
|
Sign up to set email alerts
|

Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease

Abstract: Studies of acetylcholine degrading enzymes acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) in Alzheimer’s disease (AD) suggested their potential role in the development of fibrillar amyloid-β (Aβ) plaques (amyloid plaques). A recent GWAS analysis identified a novel association between genetic variations in the BCHE locus and amyloid burden. We studied BChE immunoreactivity in hippocampal tissue sections from AD and control cases, and examined its relationship with amyloid plaques, neurofibrillary … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 38 publications
0
2
0
Order By: Relevance
“…Both AChE and BuChE hydrolyze ACh into choline and acetate to terminate its activity at synapses. In the brain, AChE is mostly found within synaptic clefts between neurons ( 57 , 58 ), while BuChE is mainly located outside the synaptic cleft and in glial cells ( 59 , 60 ). Both AChE and BuChE are present at the mouse neuromuscular junction, but exhibit different localization patterns.…”
Section: Cholinergic Components Expressed In Immune Cellsmentioning
confidence: 99%
“…Both AChE and BuChE hydrolyze ACh into choline and acetate to terminate its activity at synapses. In the brain, AChE is mostly found within synaptic clefts between neurons ( 57 , 58 ), while BuChE is mainly located outside the synaptic cleft and in glial cells ( 59 , 60 ). Both AChE and BuChE are present at the mouse neuromuscular junction, but exhibit different localization patterns.…”
Section: Cholinergic Components Expressed In Immune Cellsmentioning
confidence: 99%
“…Meanwhile, cholinergic hypothesis, the earliest theory, is based on the deficit in acetylcholine (ACh) level, which is a cholinergic neurotransmitter that is hydrolyzed by acetylcholinesterase (AChE) [ 8 , 9 , 10 , 11 , 12 ]. Relevantly, butyrylcholinesterase (BChE), the sister enzyme of AChE of the serine hydrolase class, has broader varieties of substrates compared with AChE that can also inhibit ACh [ 13 ]; BChE has been histochemically found to accumulate in β -amyloid rich-senile plaques in the brain [ 14 , 15 , 16 , 17 ]. At present, only two drug classes, i.e., cholinesterase inhibitors (i.e., tacrine, rivastigmine, donepezil, and galanthamine) and N -methyl-D-aspartate (NMDA) antagonists (i.e., memantamine), have been used for the treatment of AD [ 18 , 19 , 20 , 21 , 22 , 23 ].…”
Section: Introductionmentioning
confidence: 99%